S&P 500   3,258.59 (+0.37%)
DOW   26,853.30 (+0.14%)
QQQ   268.01 (+0.99%)
AAPL   110.19 (+1.82%)
MSFT   205.89 (+1.33%)
FB   250.66 (+0.45%)
GOOGL   1,423.02 (+0.01%)
AMZN   3,039.75 (+0.66%)
TSLA   405.31 (+4.52%)
NVDA   505.33 (+2.31%)
BABA   267.67 (-0.76%)
CGC   13.99 (-1.96%)
GE   6.03 (-0.50%)
MU   48.26 (-2.45%)
AMD   76.53 (+0.94%)
T   27.76 (-1.00%)
F   6.52 (-2.10%)
ACB   5.01 (-3.65%)
GILD   61.92 (-0.53%)
NFLX   476.41 (+0.70%)
DIS   122.11 (-0.31%)
BAC   23.22 (-0.51%)
BA   150.66 (+3.16%)
S&P 500   3,258.59 (+0.37%)
DOW   26,853.30 (+0.14%)
QQQ   268.01 (+0.99%)
AAPL   110.19 (+1.82%)
MSFT   205.89 (+1.33%)
FB   250.66 (+0.45%)
GOOGL   1,423.02 (+0.01%)
AMZN   3,039.75 (+0.66%)
TSLA   405.31 (+4.52%)
NVDA   505.33 (+2.31%)
BABA   267.67 (-0.76%)
CGC   13.99 (-1.96%)
GE   6.03 (-0.50%)
MU   48.26 (-2.45%)
AMD   76.53 (+0.94%)
T   27.76 (-1.00%)
F   6.52 (-2.10%)
ACB   5.01 (-3.65%)
GILD   61.92 (-0.53%)
NFLX   476.41 (+0.70%)
DIS   122.11 (-0.31%)
BAC   23.22 (-0.51%)
BA   150.66 (+3.16%)
S&P 500   3,258.59 (+0.37%)
DOW   26,853.30 (+0.14%)
QQQ   268.01 (+0.99%)
AAPL   110.19 (+1.82%)
MSFT   205.89 (+1.33%)
FB   250.66 (+0.45%)
GOOGL   1,423.02 (+0.01%)
AMZN   3,039.75 (+0.66%)
TSLA   405.31 (+4.52%)
NVDA   505.33 (+2.31%)
BABA   267.67 (-0.76%)
CGC   13.99 (-1.96%)
GE   6.03 (-0.50%)
MU   48.26 (-2.45%)
AMD   76.53 (+0.94%)
T   27.76 (-1.00%)
F   6.52 (-2.10%)
ACB   5.01 (-3.65%)
GILD   61.92 (-0.53%)
NFLX   476.41 (+0.70%)
DIS   122.11 (-0.31%)
BAC   23.22 (-0.51%)
BA   150.66 (+3.16%)
S&P 500   3,258.59 (+0.37%)
DOW   26,853.30 (+0.14%)
QQQ   268.01 (+0.99%)
AAPL   110.19 (+1.82%)
MSFT   205.89 (+1.33%)
FB   250.66 (+0.45%)
GOOGL   1,423.02 (+0.01%)
AMZN   3,039.75 (+0.66%)
TSLA   405.31 (+4.52%)
NVDA   505.33 (+2.31%)
BABA   267.67 (-0.76%)
CGC   13.99 (-1.96%)
GE   6.03 (-0.50%)
MU   48.26 (-2.45%)
AMD   76.53 (+0.94%)
T   27.76 (-1.00%)
F   6.52 (-2.10%)
ACB   5.01 (-3.65%)
GILD   61.92 (-0.53%)
NFLX   476.41 (+0.70%)
DIS   122.11 (-0.31%)
BAC   23.22 (-0.51%)
BA   150.66 (+3.16%)
Log in
NASDAQ:AFIB

Acutus Medical Stock Forecast, Price & News

$29.98
+0.76 (+2.60 %)
(As of 09/25/2020 11:50 AM ET)
Add
Compare
Today's Range
$29.68
Now: $29.98
$30.29
50-Day Range N/A
52-Week Range
$24.00
Now: $29.98
$38.99
Volume664 shs
Average Volume258,084 shs
Market Capitalization$834.22 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. It offers AcQMap console and workstation, an advanced imaging, navigation, and mapping system for physicians to map, treat, re-map, and adjust additional therapy as needed; and Patient Electrode Kit that is required in every procedure to provide cardiac signals, catheter localization, and AcQMap system grounding. The company also provides diagnostic and monitoring devices, such as AcQMap 3D Imaging and Mapping Catheter that is used for mapping during the electrophysiology procedures; conventional diagnostic catheters, including multi-polar, steerable, and loop catheters that are used during the mapping and ablation procedures; and reprocessed diagnostic catheters, such as diagnostic, multipole, fixed, steerable, and advanced mapping and imaging catheters. In addition, the company provides access devices, which include AcQRef Introducer that provides stable electrical reference and vascular access; AcQGuide MAX Steerable Introducer, which provides a stable platform for catheter passage and precision placement; and Transseptal Access Products. Further, it offers therapeutic devices, such as AcQBlate FORCE Ablation Catheters, AlCath Ablation Catheters, MedFact Robotic Navigation Enabled Ablation Catheters, Qubic Force, Qubic RF Generator and Pulse Stimulator, and Qiona Pump. The company also provides various software mapping modes comprises single position, supermap, contact mapping, and stereotaxis integration. Acutus Medical, Inc. was founded in 2011 and is based in Carlsbad, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.4Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.73 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AFIB
CUSIPN/A
CIKN/A
Phone442-232-6080

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees224
Market Cap$834.22 million
Next Earnings Date12/17/2020 (Estimated)
OptionableNot Optionable
$29.98
+0.76 (+2.60 %)
(As of 09/25/2020 11:50 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AFIB News and Ratings via Email

Sign-up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Acutus Medical (NASDAQ:AFIB) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Acutus Medical?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acutus Medical in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Acutus Medical
.

When is Acutus Medical's next earnings date?

Acutus Medical is scheduled to release its next quarterly earnings announcement on Thursday, December 17th 2020.
View our earnings forecast for Acutus Medical
.

How were Acutus Medical's earnings last quarter?

Acutus Medical (NASDAQ:AFIB) released its quarterly earnings results on Thursday, September, 17th. The company reported ($32.24) earnings per share for the quarter, missing the consensus estimate of ($0.83) by $31.41.
View Acutus Medical's earnings history
.

What price target have analysts set for AFIB?

6 Wall Street analysts have issued 1 year target prices for Acutus Medical's stock. Their forecasts range from $38.00 to $40.00. On average, they expect Acutus Medical's stock price to reach $38.75 in the next year. This suggests a possible upside of 29.3% from the stock's current price.
View analysts' price targets for Acutus Medical
.

Who are some of Acutus Medical's key competitors?

What other stocks do shareholders of Acutus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include salesforce.com (CRM), Docusign (DOCU), Oak Street Health (OSH), Adobe (ADBE), Alibaba Group (BABA), Walt Disney (DIS), Marvell Technology Group (MRVL), NVIDIA (NVDA), Splunk (SPLK) and Tesla (TSLA).

Who are Acutus Medical's key executives?

Acutus Medical's management team includes the following people:
  • Mr. R. Scott Huennekens M.B.A., CPA, Exec. Chairman (Age 56, Pay $286k)
  • Mr. Vincent J. Burgess, Pres, CEO & Director (Age 55, Pay $532.32k)
  • Mr. Gary W. Doherty, Chief Financial Officer (Age 54, Pay $365.9k)
  • Mr. Steven P. McQuillan, Sr. VP of Regulatory & Clinical Affairs (Age 58, Pay $402.13k)
  • Mr. Richard M. Kimes, Sr. VP of Operations (Age 58)

When did Acutus Medical IPO?

(AFIB) raised $126 million in an initial public offering on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Acutus Medical's stock symbol?

Acutus Medical trades on the NASDAQ under the ticker symbol "AFIB."

When did the company's quiet period expire?

Acutus Medical's quiet period expired on Tuesday, September 15th. Acutus Medical had issued 8,823,529 shares in its public offering on August 6th. The total size of the offering was $158,823,522 based on an initial share price of $18.00. During the company's quiet period, insiders and any underwriters that worked on the IPO were restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Acutus Medical?

Shares of AFIB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Acutus Medical's stock price today?

One share of AFIB stock can currently be purchased for approximately $29.98.

How big of a company is Acutus Medical?

Acutus Medical has a market capitalization of $834.22 million. Acutus Medical employs 224 workers across the globe.

What is Acutus Medical's official website?

The official website for Acutus Medical is www.acutusmedical.com.

How can I contact Acutus Medical?

Acutus Medical's mailing address is 2210 FARADAY AVE SUITE 100, CARLSBAD CA, 92008. The company can be reached via phone at 442-232-6080 or via email at [email protected]

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.